Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Echinacea (Immulant) in Cryptosporidiosis in Immunocompromised Children
NCT07388615Phase 2Recruiting
- Sponsor
- Al-Azhar University
- Start
- Jan 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of echinacea extract in cryptosporidiosis, sponsored by Al-Azhar University. Started Jan 2026; status: recruiting.
02
Drugs
echinacea extract
03
Conditions
cryptosporidiosis
Beyond the preview
Go deeper on NCT07388615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07388615.